Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Related Research units
Abstract
The objective of this study was to identify the role of dimethylarginine dimethylaminohydrolase-1 (DDAH1) in degrading the endogenous nitric oxide synthase inhibitors asymmetrical dimethylarginine (ADMA) and N(g)-monomethyl-L-arginine (L-NMMA).
Bibliographical data
| Original language | English |
|---|---|
| Article number | 7 |
| ISSN | 1079-5642 |
| Publication status | Published - 2011 |
| pubmed | 21493890 |
|---|
